Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Go back to Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 148.09 +7.75 (5.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $140.34 | 52 Week High | $0.52 | |||
| Open | $140.25 | 52 Week Low | $0.08 | |||
| Day High | $148.28 | P/E | N/A | |||
| Day Low | $138.09 | EPS | $-3.80 | |||
| Volume | 10,455,941 | |||||
